A subset of chromosomal translocations that participate in leukemia involve activated tyrosine kinases. The ets transcription factor, TEL, undergoes translocations with several distinct tyrosine kinases including JAK2. TEL-JAK2 transforms cell lines to factor-independence and constitutive tyrosine kinase activity results in the phosphorylation of several substrates including STAT1, STAT3 and STAT5.
INTRODUCTION
Chromosomal translocations play a central role in the development of leukemia. The participating genes generally fall into three groups involving tyrosine kinases, transcription factors or factors that modify transcriptional activation (1) . The prototypical tyrosine kinase is the BCR-ABL translocation which is the causative agent in chronic myelogenous leukemia (2) .
The ets transcription factor, TEL, is a frequent participant in chromosomal translocations, and a subset of these fusions involve tyrosine kinases including PDGFβR (3), ABL (4, 5) , ARG (6), TRKC (7, 8) and JAK2 (9, 10) . We are particularly interested in characterizing the properties of the TEL-JAK2 translocation that mediate leukemogenesis.
TEL-JAK2 translocations have been described in three patients to date. Two patients, each harboring primary translocations were diagnosed with acute lymphoblastic leukemia (ALL). One patient expressed a fusion of TEL exon 4 to JAK2 exon 17 (t(9;12)(p24;p13); TEL-JAK2 (4-17)) (9) , whereas the other had a TEL exon5 to JAK2 exon 19 translocation (t(9;12)(p24;p13); TEL-JAK2 (5-19)) (10) . The third isolated TEL-JAK2 product arose from a compound t(9;12;15)(p24;q15;p13) translocation in which one allele of TEL was fused to JAK2 (TEL-JAK2 (5-12)) (9) and the other TEL allele was fused to EVI1 (11). All three fusions have been shown to convert IL-3 dependent hematopoietic cells to factor-independence (10, 12) .
Many studies have focused on the mechanism of constitutive activation mediated by BCR-ABL. Substrates that are activated downstream of BCR-ABL include STAT1 (13) (14) (15) , STAT3 (15) , STAT5 (13) (14) (15) (16) and STAT6 (15) . Grb2-Sos can be recruited to BCR-ABL either directly or indirectly through other adaptor proteins including Ship1 (17) , Shp2 (18) , Shc (19) (20) (21) (22) (23) and Cbl (24-28). BCR-ABL has also been shown to stimulate activation of Ras (29) and the related family member Rac (30). (42) . However, a constitutively activated form of STAT5 resulted in only a myeloproliferative disease (42) . In summation, these elegant studies have shown that signaling pathways distinct from STAT5a/b activation play a role in leukemogenesis mediated by TEL-JAK2. The goal of this study is to characterize PI 3' kinase-dependent signaling mitigated by TEL-JAK2.
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Immunoprecipitations
Immunoprecipitations were performed with 1.5 mg of protein lysates. Primary antibody was added for 1 hr, followed by 1 hr incubation with Protein A-Sepharose (Amersham Pharmacia Biotech). Alternatively, primary antibody and Protein A-Sepharose was added together and incubations were performed overnight. Bead-bound immune complexes were washed 3 times with ice cold lysis buffer, eluted by boiling for 5 minutes in Laemmli sample buffer containing 100 µM DTT, and separated by SDS-PAGE and transferred to PVDF transfer membrane for immunoblotting.
In vitro Mixes -GST fusion protein binding experiments
GST fusion proteins (2.5 µg) expressing the amino, carboxy, or amino and carboxy terminal SH2 domains of p85 (generously provided by Dr Ben Margolis, U of M, Ann Arbor, MI) or GST alone immobilized to Glutathione sepharose 4B beads (Amersham Pharmacia Biotech), were incubated with 1.5 mg of protein lysates. After a 1 hour incubation at 4°C, the precipitate was washed 3 times with ice cold lysis buffer. Samples were boiled for 5 minutes in Laemmli sample buffer with 100 µM DTT to elute proteins before separation on SDS-PAGE gels and transfer to PVDF transfer membrane.
Immunoblotting
For most immunoblotting experiments, membranes were blocked at room temperature with 2.5% BSA in Tris-buffered saline (TBS; 50 mM Tris (pH8.0), 150 mM NaCl) for 1 hour. PVDF membranes for phospho-PKB and PKB immunoblots were blocked in 5% skim milk in TBST for 1 hour at room temperature, washed once in primary antibody dilution buffer and incubated with primary antibody (1:1000 dilution in 1% BSA in TBST) overnight at 4°C.
After 6 washes in TBST, the membrane was incubated with HRP-ProteinA (1:2000 dilution in 2.5% skim milk in TBST) for 1 hour at room temperature. The membrane was washed 6 times in TBST and visualized by ECL.
Membranes for phospho-STAT5 immunoblots were blocked in 5% milk in TBST for 1 hour at room temperature, washed 2 times in TBST and incubated with primary antibody (1:1000 dilution in 3% BSA in TBST) for 3 hours at room temperature. After 4 washes in TBST, the membrane was incubated with HRP-Protein A (1:5000 dilution in 2.5% BSA in TBST) for 1 hour at room temperature. The membrane was washed 4 times in TBST prior to visualization by ECL. For reprobing, membranes were stripped in 62.5 mM Tris-HCl (pH6.8), 2% SDS and 0.1M β-mercaptoethanol for 30 minutes at 50°C, and rinsed twice in TBST.
Apoptosis assays
Annexin V, 7AAD and 10X binding buffer were purchased from PharMingen. Briefly, at distinct time points, untreated and treated cells were washed in 1X binding buffer (10 mM Hepes (pH7.4), 140 mM NaCl, 2.5 mM CaCl 2 ). 1x10 6 cells were then resuspended in 50 µL 1X binding buffer and incubated with 2 µL Annexin V antibody conjugated to PE for 10 minutes at room temperature. Samples were adjusted to a final volume of 1 mL prior to FACS analysis (Becton Dickinson). Acquisition and analysis were performed using the CellQuest software.
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http://www.jbc.org/ Downloaded from RESULTS TEL-JAK2 isoforms have been constructed with breakpoints as described from patient samples (9,10) ( Figure 1 ). These constructs were introduced into the murine IL-3 dependent myeloid cell line Ba/F3 via electroporation. TEL-JAK2 (4-17), TEL-JAK2 (5-19) and TEL-JAK2 (5-12) subclones were isolated by limiting dilution and those displaying similar expression were selected for further characterization. Expression of TEL-JAK2 in Ba/F3 cells resulted in factor-independent proliferation and constitutive tyrosine phosphorylation of each fusion protein in all subclones, consistent with previous reports (10, 12) .
TEL-JAK2 fusion proteins constitutively activate Protein Kinase B(PKB)/Akt.
Growth factors and cytokines, including IL-3, induce the activity of PI 3' kinases. In addition, oncogenic tyrosine kinase fusions have been shown to activate PI 3' kinase. The transforming ability of BCR-ABL has been shown to require the PI 3' kinase signaling pathway and activation of the serine-threonine kinase PKB (45) . PKB is one downstream component of the PI 3' kinase signaling pathway important in influencing cell survival. We were interested in determining whether TEL-JAK2 mediated PKB activation ( Figure 2 
PI 3' Kinase Activation is Required for TEL-JAK2 Mediated Cell Proliferation/Survival
To determine whether TEL-JAK2 mediated factor-independent growth was dependent on lysates were immunoprecipitated with preimmune IgG or anti-TEL (lanes 1 to 8). The remaining supernatant was then incubated with GST or GST-p85 N+C SH2 fusion proteins (lanes 9 to 19). 
A Potential p85 Binding Motif in TEL-JAK2 is Dispensable for TEL-JAK2 Mediated Proliferation, PI 3' Kinase Activation and p85 Association with TEL-JAK2 (5-19)
The SH2 
The Scaffolding Protein Gab2 is a Possible Mediator of PI 3' Kinase Association with TEL-JAK2
The involvement of adaptor molecules is widespread in linking signaling pathways. With the suggestion that direct recruitment of p85 to TEL-JAK2 via the YMIM motif is not significant, we next investigated the possibility of adaptor molecules mediating the association between TEL-JAK2 and p85. Gab2 (37) has been shown to contain multiple consensus p85
binding sites thereby mediating PI 3' kinase signaling downstream of cytokine, growth factor and antigen receptor activation (37,38). 
Expression of TEL-JAK2 Protects Ba/F3 Cells from Apoptosis
We have demonstrated an association between TEL-JAK2 and PI 3' kinase and the significance of this pathway in factor-independent growth. However, PI 3' kinase and PKB have also been implicated in modulating protection from programmed cell death (55) (56) (57) (58) (59) . We were interested in assessing whether TEL-JAK2 expression can lead to decreased apoptosis of cells, The MEK/MAPK pathway has also been implicated in regulating apoptosis (82, 83) . However, the relevance of PI 3' kinase in TEL-JAK2 leukemogenesis will remain to be determined using murine bone marrow transplant models.
In summary, this study demonstrates the importance of PI 3' kinase in TEL-JAK2 mediated factor independent cell proliferation and phosphorylation of PKB. The association of TEL-JAK2 and the p85 subunit of PI 3' kinase is most likely mediated by adaptor proteins such as Gab2 and IRS-2. The putative p85 binding site in JAK2 is dispensable for this interaction.
Activation of the PI 3' kinase/PKB pathway is a common element observed in oncogenic progression. The requirement of this pathway for the onset of disease by TEL-JAK2 will be a subject of future investigation. 
